Sökning: "Aortic disease"
Visar resultat 1 - 5 av 187 avhandlingar innehållade orden Aortic disease.
1. Thoracic Aortic Surgery : Epidemiology, Outcomes, and Prevention of Cerebral Complications
Sammanfattning : The mortality of thoracic aortic diseases (mainly aneurysms and dissections) is high, even with surgical treatment. Epidemiology and long-term outcomes are incompletely investigated. Stroke is a major complication contributing to mortality, morbidity, and possibly to reduced quality of life. LÄS MER
2. On Pathophysiology and Treatment of Aortic Disease
Sammanfattning : Pathophysiological processes underlying abdominal aortic aneurysm (AAA) formation and aortic dissections (AD) are largely unknown. Molecular imaging of the inflammatory component may improve our understanding of AAA and AD pathophysiology. LÄS MER
3. Familial thoracic aortic aneurysms and dissections : studies on genotype and phenotype
Sammanfattning : Background: Thoracic aortic aneurysms and dissections (TAAD) have a genetic component with an estimated 20-25% of the patients having a positive family history. An aneurysm often precedes a dissection. Acute aortic dissections are associated with high mortality and morbidity, even when operated on. LÄS MER
4. Cardiovascular risk factors in aortic stenosis
Sammanfattning : Introduction: Aortic stenosis (AS) is the most common hemodynamic significant valvular heart disease and affects about 2% of the population. The incidence increases with age. When symptoms of the stenotic aortic valve disease eventually occur the 2-year mortality exceeds 50%. LÄS MER
5. Abdominal Aortic Aneurysm : Epidemiological and Health Economic Aspects
Sammanfattning : Abdominal aortic aneurysm (AAA) is a common disease that is life threatening when rupture occurs. The aims of this thesis were to study (I) the long-term survival after AAA repair, (II) the cost of repair with open (OR) and endovascular (EVAR) technique, (III) the effect of different statistical methods on interpretation of cost data, (IV) the prevalence of the disease among patients with suspected arterial disease referred to the vascular laboratory, and (V) the cost-effectiveness of selective high-risk screening. LÄS MER